Who has invested in Shanghai Raas Blood Products?

Haier are named among the investors backing Shanghai Raas Blood Products.

Shanghai Raas Blood Products Funding: $1.7B Raised, IPO

Shanghai Raas Blood Products funding overview

Shanghai Raas Blood Products is based in Shanghai, China. Shanghai Raas Blood Products has raised $1.7B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in January 2023. The round record for Shanghai Raas Blood Products runs through 2023; nothing later has been disclosed. Investors on record include Haier.

Shanghai Raas Blood Products at a glance

Total raised: $1.7B
Latest round: IPO
Latest round date: January 2023
Headquarters: Shanghai, China
Notable investors: Haier

Frequently asked about Shanghai Raas Blood Products funding

How much has Shanghai Raas Blood Products raised?: Shanghai Raas Blood Products has raised $1.7B in total disclosed funding across the rounds on record.
Who has invested in Shanghai Raas Blood Products?: Haier are named among the investors backing Shanghai Raas Blood Products.
What was the latest Shanghai Raas Blood Products funding round?: The most recent disclosed round is an IPO, announced in January 2023.
Where is Shanghai Raas Blood Products based?: Shanghai Raas Blood Products is based in Shanghai, China.
When did Shanghai Raas Blood Products last raise?: The last disclosed Shanghai Raas Blood Products round closed in January 2023 at IPO.

Totals shown for Shanghai Raas Blood Products aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.

Shanghai Raas Blood Products Funding: $1.7B Raised, IPO

Shanghai Raas Blood Products funding overview

Shanghai Raas Blood Products at a glance

Frequently asked about Shanghai Raas Blood Products funding

Companies related to Shanghai Raas Blood Products (19)

Browse related funding lists (5)